A meta-analysis on heart rate variability biofeedback and depressive symptoms.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 03 2021
Historique:
received: 05 11 2020
accepted: 08 03 2021
entrez: 24 3 2021
pubmed: 25 3 2021
medline: 25 2 2023
Statut: epublish

Résumé

Heart rate variability biofeedback (HRVB) has been used for a number of years to treat depressive symptoms, a common mental health issue, which is often comorbid with other psychopathological and medical conditions. The aim of the present meta-analysis is to test whether and to what extent HRVB is effective in reducing depressive symptoms in adult patients. We conducted a literature search on Pubmed, ProQuest, Ovid PsycInfo, and Embase up to October 2020, and identified 721 studies. Fourteen studies were included in the meta-analysis. Three meta-regressions were also performed to further test whether publication year, the questionnaire used to assess depressive symptoms, or the interval of time between T0 and T1 moderated the effect of HRVB. Overall, we analysed 14 RCTs with a total of 794 participants. The random effect analysis yielded a medium mean effect size g = 0.38 [95% CI = 0.16, 0.60; 95% PI =  - 0.19, 0.96], z = 3.44, p = 0.0006. The total heterogeneity was significant, Q

Identifiants

pubmed: 33758260
doi: 10.1038/s41598-021-86149-7
pii: 10.1038/s41598-021-86149-7
pmc: PMC7988005
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

6650

Références

Psychol Med. 2017 Nov;47(15):2578-2586
pubmed: 28478782
Appl Psychophysiol Biofeedback. 2017 Sep;42(3):235-245
pubmed: 28573597
Neuropsychiatr Dis Treat. 2015 Oct 09;11:2619-27
pubmed: 26557753
J Affect Disord. 2016 Sep 15;202:67-86
pubmed: 27253219
J Affect Disord. 2018 Aug 1;235:456-466
pubmed: 29679898
J Eval Clin Pract. 2011 Aug;17(4):594-6
pubmed: 21679280
Arch Intern Med. 2000 Jul 24;160(14):2101-7
pubmed: 10904452
J Affect Disord. 2017 Oct 15;221:36-46
pubmed: 28628766
Int J Psychophysiol. 2014 Jul;93(1):105-11
pubmed: 23684733
Front Psychiatry. 2019 Jan 17;9:735
pubmed: 30705641
Psychiatry Res. 2018 Oct;268:243-250
pubmed: 30071387
Acta Cardiol. 2014 Jun;69(3):299-307
pubmed: 25029875
Can J Psychiatry. 2013 Jul;58(7):376-85
pubmed: 23870719
Int J Psychophysiol. 2018 Sep;131:96-101
pubmed: 29307738
Ecancermedicalscience. 2019 Mar 28;13:914
pubmed: 31123497
Front Psychol. 2017 Jan 24;8:31
pubmed: 28174547
Appl Psychophysiol Biofeedback. 2000 Sep;25(3):177-91
pubmed: 10999236
Diabetologia. 2006 May;49(5):837-45
pubmed: 16520921
World Psychiatry. 2017 Jun;16(2):163-180
pubmed: 28498599
Arch Neurol. 2003 May;60(5):753-9
pubmed: 12756140
Biol Res Nurs. 2020 Jan;22(1):34-44
pubmed: 31635477
J Psychosom Res. 2017 Feb;93:6-13
pubmed: 28107894
Psychosom Med. 2004 May-Jun;66(3):305-15
pubmed: 15184688
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Front Neurosci. 2020 Jul 21;14:738
pubmed: 32792897
BMC Med. 2013 May 15;11:129
pubmed: 23672628
Stress. 2015;18(3):343-52
pubmed: 26004818
Appl Psychophysiol Biofeedback. 2015 Dec;40(4):257-68
pubmed: 26111942
Chonnam Med J. 2015 Apr;51(1):8-18
pubmed: 25914875
Neuroimage. 2011 Feb 14;54(4):2643-51
pubmed: 21073959
JAMA Psychiatry. 2018 Jun 1;75(6):566-576
pubmed: 29800984
Appl Psychophysiol Biofeedback. 2020 Sep;45(3):109-129
pubmed: 32385728
J Affect Disord. 2013 Oct;151(1):343-51
pubmed: 23953024
Stroke. 2020 Jan;51(1):54-60
pubmed: 31818230
Int J Environ Res Public Health. 2019 Mar 23;16(6):
pubmed: 30909539
Lancet. 2007 Sep 8;370(9590):851-8
pubmed: 17826170
JAMA Psychiatry. 2018 Apr 1;75(4):336-346
pubmed: 29450462
Ann Gen Psychiatry. 2020 Aug 13;19:46
pubmed: 32817752
Appl Psychophysiol Biofeedback. 2020 Dec;45(4):307-322
pubmed: 32556709
Biol Psychiatry. 2010 Jun 1;67(11):1067-74
pubmed: 20138254
J Clin Psychol. 2011 Oct;67(10):1080-91
pubmed: 21905026
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
PLoS One. 2012;7(2):e30777
pubmed: 22355326
Appl Psychophysiol Biofeedback. 2009 Jun;34(2):71-91
pubmed: 19205870
Appl Psychophysiol Biofeedback. 2020 Jun;45(2):99-108
pubmed: 32358782
J Pediatr Nurs. 2022 Sep-Oct;66:151-159
pubmed: 35777250
Psychol Bull. 2017 Nov;143(11):1155-1200
pubmed: 28805400
Perm J. 2018 Sep 27;22:17-207
pubmed: 30285917
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Biometrics. 2018 Sep;74(3):785-794
pubmed: 29141096
Clin Psychopharmacol Neurosci. 2019 May 31;17(2):222-232
pubmed: 30905122
Int J Behav Med. 2018 Jun;25(3):271-282
pubmed: 29297147
Am Psychol. 2018 Nov;73(8):1019-1030
pubmed: 30394780
Front Psychol. 2014 Jul 21;5:756
pubmed: 25101026
Behav Pharmacol. 2018 Apr;29(2 and 3-Spec Issue):152-164
pubmed: 29543649
Lancet Oncol. 2011 Feb;12(2):160-74
pubmed: 21251875
Appl Psychophysiol Biofeedback. 2011 Jun;36(2):71-80
pubmed: 21365308
Nat Rev Neurosci. 2008 Oct;9(10):788-96
pubmed: 18784657
Front Public Health. 2019 Nov 05;7:323
pubmed: 31750285
Ecancermedicalscience. 2014 Feb 11;8:400
pubmed: 24567757
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Silvia F M Pizzoli (SFM)

Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy. silviafrancescamaria.pizzoli@ieo.it.
Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IEO, IRCCS, Milan, Italy. silviafrancescamaria.pizzoli@ieo.it.

Chiara Marzorati (C)

Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IEO, IRCCS, Milan, Italy.

Daniele Gatti (D)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Dario Monzani (D)

Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy.
Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IEO, IRCCS, Milan, Italy.

Ketti Mazzocco (K)

Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy.
Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IEO, IRCCS, Milan, Italy.

Gabriella Pravettoni (G)

Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy.
Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IEO, IRCCS, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH